Amazing talk..a must!!⭐️✨ State of the Art:Transgender care for urologists🌈With the one and only ⁦Polina Reyblat ❤️⁩ #AUA2024

Had to travel all the way to San Antonio to see all you wonderful people!
Best part about the #AUA24 .

Guy Verhovsky Alon Lazarovich Yuval Avda jonathan gal Azik Hoffman Rennen Haramaty
Not in pictures (but seen in the flesh!): Omer Anis Reuben Ben-David Ofer Yossepowitch

Congrats Francesco Del Giudice !

Alpha blockers help you get it (scope) up. ⁦R.O.C.K. Society⁩ #aua24

Impressive turn-out for a 7am talk! Reuben Ben-David Mount Sinai Department of Urology on preoperative circulating tumor DNA as predictor of outcome after #RadicalCystectomy .

#AUA24 #BladderCancer

Great session wrap by by Jonathan Warner on how prostate configuration can impact surgical outcomes - match the right procedure to the right prostate! #AUA24 Amer. Urol. Assn. BPDSociety #BPH #MensHealth

Comparison Between Three Contemporary Approaches of Single-Port Robotic Radical Prostatectomy: A Report from the Single-Port Advanced Research Consortium Involving 1800 Patients |Nicolas Soputro #AUA24

Oxybutynin is associated with a 12% increased risk of dementia in women over age 65 years compared to mirabegron 😧
#AUA24

UDS parameters do not seem to predict urinary retention s/p bladder Botox @AnjaliKapurMD #SURN Qmax lower ~ UR NYU Langone Urology Dr. Benjamin Brucker Una Lee Anne P Cameron W. Stuart Reynolds, MD, MPH Giulia M. Ippolito, MD, MS Priya Padmanabhan Ariana L Smith Meredith C Wasserman, MD Una Lee Jennifer Anger, MD, MPH #sufu24 #aua24

Dr. Roger R. Dmochowski discusses the use of implantable tibial neuromodulation devices as an earlier line of therapy for patients with overactive bladder. #AUA24 #OAB #urology Vanderbilt Urology
urologytimes.com/view/dr-dmocho…

If a patient failed either #SNM or bladder Botox for overactive bladder #OAB , how well would they do with the other modality?
They still have a 50-60% chance of success!
Interesting analysis by Po-Ming Chow at the #AUA24

Does cognitive impairment impact sacral neuromodulation success in older adults? | Chen Grace Shenhar #AUA24

In honor of Yom Hashoah (Holocaust remembrance day), RTing this.

For pts on #oab meds >1 year, only oxybutynin was associated with 12% increase in onset of dementia relative to b3 agonist (darifenacin, fesoterodine, solifenacin, tolterodine, trospium appear to be ok) #sufu24 at #AUA24

Neuromodulation has come a long way over the past several decades, but Rose Khavari MD⁩ & colleagues are just getting started. Now studying spine and transcranial brain modulation for #NGB (OAB in MS). ⁦Amer. Urol. Assn.⁩ ⁦Houston Methodist MD⁩ ⁦Houston Methodist Urology and Residency Program⁩ #AUA2024

Is cognitive impairment a contraindication for sacral neuromodulation? Join us at #AUA24 PD-59 / room 304A and find out!
Cleveland Clinic Urology SUFU Jacqueline Zillioux

So proud to work directly with each of these impactful women, who are amazing editorial leaders 💕 what a privilege! #AUA24

Long-Term Functional and Oncological Outcomes Following Partial Nephrectomy in Solitary Kidney Patients | Nicolas Soputro #AUA24